AVR
Anteris Technologies Global Corp.
NASDAQ · Healthcare · Medical - Devices · AU
$6.18
+2.15%Year over year
Reported trailing growth
- Revenue
- -9.6%
- EBITDA
- -20.6%
- EBIT
- -24.1%
- EPS
- +15.1%
- Free cash flow
- -17.3%
- Operating cash flow
- -17.6%
Forward estimates
Based on analyst estimates
- Revenue
- +379.5%
- EBITDA
- -11.8%
- EPS
- +57.1%
Three-year CAGR
- Revenue
- -15.8%
- EBITDA
- -24.4%
- EBIT
- -19.8%
- Net income
- -23.4%
- EPS
- +32.4%
- Free cash flow
- -25.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026